What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Immune system
His scientific interests lie mostly in COPD, Lung, Internal medicine, Immunology and Lung microbiome.
The COPD study combines topics in areas such as Chest ct, Prospective cohort study and Spirometry.
His Lung study combines topics in areas such as Pneumocystis carinii, Pneumonia, Radiology, Bronchoscopy and Pathology.
His studies in Internal medicine integrate themes in fields like Physical therapy, Intensive care medicine and Cardiology.
As a part of the same scientific family, Jeffrey L. Curtis mostly works in the field of Immunology, focusing on Cryptococcus neoformans and, on occasion, Cryptococcosis, Virulence, In vivo, Melanin and Immunity.
He has included themes like Bronchoalveolar lavage and Respiratory tract in his Lung microbiome study.
His most cited work include:
- Azithromycin for Prevention of Exacerbations of COPD (806 citations)
- Chronic obstructive pulmonary disease phenotypes: the future of COPD. (752 citations)
- Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD (611 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns COPD, Internal medicine, Immunology, Lung and Cohort.
His study in COPD is interdisciplinary in nature, drawing from both Pulmonary disease, Exacerbation, Physical therapy and Spirometry.
His research in Internal medicine intersects with topics in Gastroenterology and Cardiology.
His Immunology research focuses on Bronchoalveolar lavage and how it connects with Microbiome.
His specific area of interest is Lung, where Jeffrey L. Curtis studies Lung microbiome.
His work focuses on many connections between Immune system and other disciplines, such as Cryptococcus neoformans, that overlap with his field of interest in Cryptococcosis and Immunity.
He most often published in these fields:
- COPD (51.44%)
- Internal medicine (45.95%)
- Immunology (43.34%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (45.95%)
- COPD (51.44%)
- Cohort (15.93%)
In recent papers he was focusing on the following fields of study:
Jeffrey L. Curtis mostly deals with Internal medicine, COPD, Cohort, Lung and Immunology.
His Internal medicine research includes themes of Gastroenterology and Cardiology.
His COPD research incorporates elements of Pulmonary disease, Exacerbation, Spirometry and Airway.
His work in Cohort tackles topics such as Lung function which are related to areas like Chest ct and Radiology.
He mostly deals with Bronchoalveolar lavage in his studies of Lung.
His Immunology research is multidisciplinary, incorporating perspectives in Phenotype and Gene expression.
Between 2018 and 2021, his most popular works were:
- Noninvasive Imaging Biomarker Identifies Small Airway Damage in Severe Chronic Obstructive Pulmonary Disease. (39 citations)
- Metoprolol for the Prevention of Acute Exacerbations of COPD. (38 citations)
- COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease. (31 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Immune system
His scientific interests lie mostly in COPD, Internal medicine, Lung, Cohort and Pulmonary disease.
His work deals with themes such as Bronchitis and Randomized controlled trial, which intersect with COPD.
His studies deal with areas such as Gastroenterology and Airway as well as Internal medicine.
His Lung study combines topics from a wide range of disciplines, such as Organ system and Reproducibility.
His research integrates issues of Vital capacity, FEV1/FVC ratio and Multiplex in his study of Cohort.
The study incorporates disciplines such as Small airways, Immunology and Intensive care medicine in addition to Pulmonary disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
